about
Cationic Thiolated Poly(aspartamide) Polymer as a Potential Excipient for Artificial Tear FormulationsSponge-Like Dressings Based on the Association of Chitosan and Sericin for the Treatment of Chronic Skin Ulcers. II. Loading of the Hemoderivative Platelet LysateChitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties.Mucoadhesive behaviour of emulsions containing polymeric emulsifier.Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery.Intestinal permeability of oxytetracycline from chitosan-montmorillonite nanocomposites.Platelet lysate embedded scaffolds for skin regeneration.Skin Localization of Lipid Nanoparticles (SLN/NLC): Focusing the Influence of Formulation Parameters.Penetration and distribution of thiocolchicoside through human skin: comparison between a commercial foam (Miotens) and a drug solutionChitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanismsChitosan and its salts for mucosal and transmucosal delivery.Advances in oral controlled drug delivery: the role of drug-polymer and interpolymer non-covalent interactions.Platelet lysate mucohadesive formulation to treat oral mucositis in graft versus host disease patients: a new therapeutic approachOpportunities offered by chitosan-based nanotechnology in mucosal/skin drug delivery.Mucoadhesive and thermogelling systems for vaginal drug delivery.Sponge-Like Dressings Based on the Association of Chitosan and Sericin for the Treatment of Chronic Skin Ulcers. I. Design of Experiments-Assisted Development.In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.Development of chitosan oleate ionic micelles loaded with silver sulfadiazine to be associated with platelet lysate for application in wound healing.Chitosan-coupled solid lipid nanoparticles: Tuning nanostructure and mucoadhesion.A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers.Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid.Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity.Thermosensitive eyedrops containing platelet lysate for the treatment of corneal ulcers.Nanoparticle formulations to enhance tumor targeting of poorly soluble polyphenols with potential anticancer properties.Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury.Carvacrol/clay hybrids loaded into in situ gelling films.Application of DoE approach in the development of mini-capsules, based on biopolymers and manuka honey polar fraction, as powder formulation for the treatment of skin ulcers.Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum.Engineered microparticles based on drug-polymer coprecipitates for ocular-controlled delivery of Ciprofloxacin: influence of technological parameters.Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applicationsDrug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes.Montmorillonite-chitosan-silver sulfadiazine nanocomposites for topical treatment of chronic skin lesions: in vitro biocompatibility, antibacterial efficacy and gap closure cell motility properties.Thermally sensitive gels based on chitosan derivatives for the treatment of oral mucositis.Assessment of chitosan derivatives as buccal and vaginal penetration enhancers.Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies.Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex."Sponge-like" dressings based on biopolymers for the delivery of platelet lysate to skin chronic wounds.
P50
Q28829105-23B4048D-DBB4-42BF-AF53-657CE907DD9FQ29399352-8D9E31D1-1D46-427A-84F2-2A2A2552F08FQ33318147-EE02D7F2-B205-4535-97D8-BBB34B65C1B6Q33339107-B8B2D479-3B76-4447-9273-56420759933DQ33363001-CC821102-54AE-4AF4-AD4A-FF96B0E43B81Q33541093-15319F67-D2B4-4DA4-9291-7B1E7691D6A8Q33733579-6E0D2860-18A8-4DC5-B9A5-82AB0DCD57A8Q33857681-750BE989-8301-45AA-8D60-00B1BCA931F2Q35056787-5ED1CC19-BC2F-4307-8A5C-3F3B68209B13Q35314235-02AF39F1-2CDD-436A-9376-2394A4C8B6BCQ35883594-B825EAB4-18D3-4D0A-98F2-5B37DE99A490Q37065949-6F76B012-46A8-432F-8BBB-2C12E164121FQ37360605-B65BB10D-756E-484D-A085-225991207224Q37564537-CB6BCEC1-ABA7-4400-B937-E8890CCB642AQ38255405-B9A96802-61E7-4791-A398-1453C9599429Q38312087-01952045-76AA-454A-B982-108E214F294AQ38314570-BAF86635-D759-4A64-9F09-E650C85E45ECQ38356355-C7F7E086-FA62-400E-9E77-CE42436ED2BCQ38793460-2D63789C-FED1-4F9F-AF76-66AE60177E56Q38820385-E897C46B-8F66-41C2-8DBA-AFC39F2A824DQ38965433-D6D689E5-543A-4CF9-8D57-2736FD64E7A1Q39090651-0BAF86BD-2C43-4002-B58E-400C3F0AEBF3Q39261715-CD593188-D8F4-40DF-B57C-F3591E29E772Q39266039-3471EA83-3FC0-4256-8DC7-68A8974CCE61Q39315974-A36FF878-4F83-4A0C-9066-FC07EB655550Q39411590-2842C622-B5A0-416E-AE0C-8F27A21BF533Q39412151-CDE7C97E-F697-4954-9181-8B6A79BBF1F3Q39415268-9D7C003A-A43A-4551-AB52-1E510425557CQ40170547-E405F53E-E2E4-4C82-A9BF-87101A521785Q40478858-E615B263-0DF3-4D0D-AC6F-A6D0DAF8AED8Q40523339-9A49CF5D-E496-4C80-8BD9-B7740696D930Q40945338-332BEC36-85D1-4005-8167-73E7FB67E649Q42111809-555F7274-5702-409C-8DB1-2B1AC32890D8Q42181178-EA1E090C-A1D4-4718-ABBB-C1F25AD51924Q42238327-5E5828FE-15AB-49A8-9F54-0A14F89C787DQ43255568-9B914341-90F9-4C10-8D67-AFA23FD761DFQ44752345-54F2E76D-6BC6-4076-8A5A-E5FF77A92D13Q44848894-A2280E76-B1C6-4B50-86BB-F72C44203C5BQ44940505-F999E4B9-4BE0-41C3-9F80-3F884DC48F2BQ45035283-E2E4E662-9624-44A6-86B9-B939667F7C17
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Cristina Bonferoni
@ast
Maria Cristina Bonferoni
@en
Maria Cristina Bonferoni
@es
Maria Cristina Bonferoni
@nl
Maria Cristina Bonferoni
@sl
type
label
Maria Cristina Bonferoni
@ast
Maria Cristina Bonferoni
@en
Maria Cristina Bonferoni
@es
Maria Cristina Bonferoni
@nl
Maria Cristina Bonferoni
@sl
prefLabel
Maria Cristina Bonferoni
@ast
Maria Cristina Bonferoni
@en
Maria Cristina Bonferoni
@es
Maria Cristina Bonferoni
@nl
Maria Cristina Bonferoni
@sl
P106
P1153
7004292071
P21
P31
P496
0000-0002-1194-9372